Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: Japan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20091
20101
20121
20161
20171
20183
20211
20231
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Completed6
Recruiting4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
National Cancer Institute (NCI)3
Amgen2
AstraZeneca2
AbbVie1
Eli Lilly and Company1
Genmab1
Hoffmann-La Roche1
Japanese Gynecologic Oncology Group1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms18
Ovarian Neoplasms16
Carcinoma, Ovarian Epithelial5
Peritoneal Neoplasms3
Brenner Tumor2
Neoplasms2
Adenocarcinoma, Clear Cell1
Adenocarcinoma, Mucinous1
Carcinoma1
Neoplasm Metastasis1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.